Burn wounds infected by contaminated water: Case reports, review of the literature and recommendations for treatment

Burns

Volumn 36, Issue 1, 2010, Pages 9-22

  Ribeiro, Noel F F ^a   Heath, Christopher H ^a,b   Kierath, Jessica ^b   Rea, Suzanne ^a   Duncan Smith, Mark ^a   Wood, Fiona M ^a,c,d  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

Aeromonas hydrophila; Bacillus cereus; Burns infection; Mucormycosis; Water borne infection; Water exposure; Zygomycosis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CIPROFLOXACIN; COTRIMOXAZOLE; FLUCLOXACILLIN; FLUCONAZOLE; GENTAMICIN; MEROPENEM; VANCOMYCIN;

ADD ON THERAPY; ADULT; AEROMONAS HYDROPHILA; ALGORITHM; ANTIMICROBIAL THERAPY; BACILLUS CEREUS; BURN; CASE REPORT; CHEMOTHERAPY; DEBRIDEMENT; DRUG SUBSTITUTION; FASCIA; FIRE; HUMAN; HUMAN TISSUE; LEG AMPUTATION; MUCORMYCOSIS; NONHUMAN; REVIEW; RHIZOMUCOR; SKIN GRAFT; WATER CONTAMINATION; WATER IMMERSION; WOUND INFECTION;

ADOLESCENT; ADULT; AEROMONAS; AGED; AGED, 80 AND OVER; BACILLUS CEREUS; BURNS; CHILD; FIRST AID; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; SOIL MICROBIOLOGY; WATER MICROBIOLOGY; WATER POLLUTION; WOUND INFECTION; YOUNG ADULT; ZYGOMYCOSIS;

EID: 72049130263     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2009.03.002     Document Type: Review

References (67)

1. Church D., Elsayed S., Reid O., Winston B., and Lindsay R. Burns wound infections. Clin Microbiol Rev 19 (2006) 403-434
2. Kienzle N., Muller M., and Pegg S. Aeromonas wound infection in burns. Burns 26 (2000) 478-482
3. Prudue G.F., and Hunt J.L. Aeromonas hydrophila infection in burn patients. Burns Incl Therm Inj 14 (1988) 220-221
4. Mayhall G.C. The epidemiology of burn wound infections: then and now. Clin Infect Dis 37 (2003) 543-550
5. Noonburg G.E. Management of extremity trauma and related infections occurring in the aquatic environment. J Am Acad Orthop Surg 13 (2005) 243-253
6. Heath C.H., Garrow S., and Golledge C.L. Non-O1 Vibrio cholerae: a fatal cause of sepsis in Northern Australia. Med J Aust 174 (2001) 480-481
7. Steinberg J.P., and Del Rio C. Other Gram-negative and Gram-variable bacilli. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious diseases. 6th ed. (2005), Elsevier Churchill Livingstone, New York 2751-2768 [chapter 234]
8. Auerbach P.S., Yajiko D.M., Nassos P.S., Kizer K.W., Morris Jr. J.A., and Hadley W.K. Bacteriology of the freshwater environment: implications for clinical therapy. Ann Emerg Med 16 (1987) 1016-1022
9. Beckert B.W., Puckett C.L., and Concannon M.J. Analysis of freshwater pathogens: a guide to rational empiric antibiotic coverage. Mol Med 101 (2004) 219-221
10. Burke V., Robinson J., Gracey M., Peterson D., Meyer N., and Haley V. Isolation of Aeromonas hydrophila from a metropolitan water supply: seasonal correlation with clinical isolates. Appl Environ Microbiol 48 (1984) 361-366
11. Semel J.D., and Trenholme G. Aeromonas hydrophila water-associated traumatic wound infections: a review. J Trauma 30 (1990) 324-327
12. Chim H., and Song C. Aeromonas infection in critically ill burn patients. Burns 33 (2007) 756-759
13. Lai C.C., Shiao C.C., Lu G.D., and Ding L.W. Aeromonas hydrophila and Aeromonas sobria bacteremia: rare pathogens of infection in a burn patient. Burns 33 (2007) 255-257
14. Wilcox R.A., Chin G.K., and Sengasothy M. Aeromonas hydrophila infection secondary to an electric burn. Med J Aust 173 (2000) 219-220
15. Ko W.C., Lee H.C., Chuang Y.C., Liu C.C., and Wu J.J. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia. J Infect 40 (2000) 267-273
16. Skoll P.J., Hudson D.A., and Simpson J.A. Aeromonas hydrophila in burn patients. Burns 24 (1998) 350-353
17. Barillo D.J., McManus A.T., Cioffi W.G., McManus W.F., Kim S.H., and Pruitt Jr. B.A. Aeromonas bacteraemia in burn patients. Burns 22 (1996) 48-52
18. Ampel N., and Peter G. Aeromonas bacteraemia in a burn patient. Lancet 318 (1981) 987
19. Phillips J.A., Bernhardt H.E., and Rosenthal S.G. Aeromonas hydrophilia infections. Pediatrics 53 (1974) 110-112
20. Smith J.A. Aeromonas hydrophilia: analysis of 11 cases. Can Med Assoc J 122 (1980) 1270-1272
21. Janda J.M., and Abbott S.L. Evolving concepts regarding the genus Aeromonas: an expanding panorama of species, disease presentations, and unanswered questions. Clin Infect Dis 27 (1998) 332-344
22. Hiransuthikul N., Tantisiriwat W., Lertutsahakul K., Vibhagool A., and Boonma P. Skin and soft-tissue infections among tsunami survivors in southern Thailand. Clin Infect Dis 41 (2005) e93-e96
23. Vally H., Whittle A., Cameron S., Dowse G.K., and Watson T. Outbreak of Aeromonas hydrophila wound infections associated with mud football. Clin Infect Dis 38 (2004) 1084-1089
24. Kinney K.S., Austin C.E., Morton D.S., and Sonnenfeld G. Catecholamine enhancement of Aeromonas hydrophila growth. Microb Pathog 26 (1999) 85-91
25. Clinical Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing for infrequently isolated or fastidious bacteria: proposed guideline. Document M45-P, National Committee for Clinical Laboratory Standards Institute, Wayne, PA, USA; 2006.
26. Wong T.Y., Tsui H.Y., So M.K., Lai J.Y., Lai S.T., Tse C.W., et al. Plesiomonas shigelloides infection in Hong Kong: retrospective study of 167 laboratory-confirmed cases. Hong Kong Med J 6 (2000) 375-380
27. Slaven E.M., Lopez F.A., Hart S.M., and Saunders C.V. Myonecrosis caused by Edwardsiella tarda: a case report and case series of extraintestinal E. tarda infections. Clin Infect Dis 32 (2001) 1430-1433
28. Fekete T. Bacillus species and related genera other than Bacillus anthracis. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious diseases. 6th ed. (2005), Elsevier Churchill Livingstone, New York 2493-2496 [chapter 206]
29. Darbar A., Harris I.A., and Gosbell I.B. Necrotizing infection due to Bacillus cereus mimicking gas gangrene following penetrating trauma. J Orthop Trauma 19 (2005) 353-355
30. Drobniewski F.A. Bacillus cereus and related species. Clin Microbiol Rev 6 (1993) 324-338
31. Heath C.H., Orrell C.T., Lee R.C.E., Pearman J.W., Lambert E., McCullough C., et al. Multi-drug resistant organisms at Royal Perth Hospital following the Bali disaster. Aust Infect Control 8 (2003) 43-54
32. Cooter R.D., Lim I.S., Ellis D.H., and Leitch I.O.W. Burn wound zygomycosis caused by Apophysomyces elegans. J Clin Microbiol 28 (1990) 2151-2153
33. Ribeiro N.F.F., Cousin G.C.S., Wilson G.E., Butterworth D.M., and Woodwards R.T. Lethal invasive mucormycosis: case report and recommendations for treatment. Int J Oral Maxillofac Surg 30 (2001) 156-159
34. Page R., Gardam D.J., and Heath C.H. Severe cutaneous mucormycosis (zygomycosis) due to Apophysomyces elegans. ANZ J Surg 71 (2001) 184-186
35. Andresen D., Donaldson A., Choo L., Knox A., Klaassen M., Ursic C., et al. Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka. Lancet 365 (2005) 876-878
36. van Burik J.-A., Hare R.S., Solomon H.F., Corrado M.L., and Kontoyiannis D.P. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 42 (2006) e61-e65
37. MacMillan B.G. The control of burn wound sepsis. Intensive Care Med 2 (1981) 63-69
38. John B.V., Chamilos G., and Kontoyiannis D.P. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect 11 (2005) 515-517
39. Barratt D.M., Van Meter K., Asmar P., Nolan T., Trahan C., Garcia-Covarrubias L., et al. Hyperbaric oxygen as an adjunct in zygomycosis: randomized controlled trial in a murine model. Antimicrob Agents Chemother 45 (2001) 3601-3602
40. Auerbach P.S., Yajko D.M., Nassos P.S., Kizer K.W., McCosker J.E., Geehr E.C., et al. Bacteriology of the marine environment: implications for clinical therapy. Ann Emerg Med 16 (1987) 643-649
41. Bross M.H., Soch K., Morales R., and Mitchell R.B. Vibrio vulnificus infection: diagnosis and treatment. Am Fam Physician 76 (2007) 539-544
42. Centre for Disease Control, and Prevention. Vibrio illness after hurricane Katrina-multiple states. MMWR Morb Mortal Wkly Rep 54 August-September (2005) 928-931
43. Regules J.A., Horvath L.L., and Chung K.K. Invasive Vibrio cholerae infection following burn injury. J Burn Care Res 29 (2008) 551-554
44. Magnusson M.R., and Pegg S.P. Vibrio cholerae non-O1 primary septicaemia following a large thermal burn. Burns 22 (1996) 44-47
45. Shannon J.D., and Kimbrough III R.C. Pulmonary cholera due to infection with a non-O1 Vibrio cholerae strain. J Clin Microbiol 44 (2006) 3459-3460
46. Holt H.M., Gahrn-Hansen B., and Bruun B. Shewanella algae and Shewanella putrefaciens: clinical and microbiological characteristics. Clin Microbiol Infect 11 (2005) 347-352
47. Chen Y.S., Liu Y.C., Yen M.Y., Wang J.H., Wang J.H., Wann S.R., et al. Skin and soft-tissue manifestations of Shewanella putrefaciens infection. Clin Infect Dis 25 (1997) 225-229
48. Gram L., Bundvad A., Melchiorsen J., Johansen C., and Fonnesbech Vogel B. Occurrence of Shewanella algae in Danish costal water and effects of water temperature and culture conditions on its survival. Appl Environ Microbiol 65 (1999) 3896-3900
49. Brooke C.J., and Riley T.V. Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. J Med Microbiol 48 (1999) 789-799
50. Venditti M., Gelfusa V., Tarasi A., Brandimarte C., and Serra P. Antimicrobial susceptibilities of Erysipelothrix rhusiopathiae. Antimicrob Agents Chemother 34 (1990) 2038-2040
51. Rallis E., and Koumantaki-Mathioudaki E. Treatment of Mycobacterium marinum cutaneous infections. Expert Opin Pharmacother 8 (2007) 2965-2978
52. Kargel J.S., Dimas V.M., Kao D.S., Heggers J.P., Chang P., and Phillips L.G. Empiric antibiotic therapy for seawater injuries: a four-seasonal analysis. Plast Reconstr Surg 121 (2008) 1249-1255
53. Greenhalgh D.G., Saffle J.R., Holmes IV J.H., Gamelli R.L., Palmieri T.L., Horton J.W., et al. American Burn Association Consensus Conference to define sepsis and infection in burns. J Burn Care Res 28 (2007) 776-790
54. Barati M., Alinejad F., Bahar M.A., Tabrisi M.S., Shamshiri A.R., Bodouhi N.O., et al. Comparison of WBC, ESR, CRP and PCT serum levels in septic and non-septic burn cases. Burns 34 (2008) 770-774
55. Lavrentieva A., Kontakiotis T., Lazaridis L., Tsotsolis N., Koumis J., Kyriazis G., et al. Inflammatory markers in patients with severe burn injury what is the best indicator of sepsis?. Burns 33 (2007) 189-194
56. Bargues L., Chancerelle Y., Catineau J., Jault P., and Carsin H. Evaluation of serum procalcitonin concentration in the ICU following severe burn. Burns 33 (2007) 860-864
57. Tang B.M.P., Eslick G.D., Craig J.C., and McLean A.S. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systemic review and meta-analysis. Lancet Infect Dis 7 (2007) 210-217
58. Harrison-Balestra C., Cazzaniga A.L., Davis S.C., and Mertz P.M. A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 h and is visualized by light microscopy. Dermatol Surg 29 (2003) 631-635
59. Yoon S.S., Coakley R., Lau G.W., Lymar S.V., Gaston B., Karabulut A.C., et al. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J Clin Invest 116 (2006) 436-446
60. Sharma M., Visai L., Bragheri F., Cristiani I., Gupta P.K., and Speziale P. Toluidine blue-mediated photodynamic effects on staphylococcal biofilms. Antimicrob Agents Chemother 52 (2008) 299-305
61. Raad I.I., Fang X., Keutgen X.M., Jiang Y., Sherertz R., and Hachem R. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 21 (2008) 385-392
62. Gallant C.V., Daniels C., Leung J.M., Ghosh A.S., Young K.D., Kotra L.P., et al. Common beta-lactamases inhibit bacterial biofilm formation. Mol Microbiol 58 (2005) 1012-1024
63. Bielecki P., Glik J., Kawecki M., and Martins dos Santos V.A. Towards understanding Pseudomonas aeruginosa burn wound infections by profiling gene expression. Biotechnol Lett 30 (2008) 777-790
64. Girard G., and Bloemberg G.V. Central role of quorum sensing in regulating the production of pathogenicity factors in Pseudomonas aeruginosa. Future Microbiol 3 (2008) 97-106
65. Moskowitz S.M., Foster J.M., Emerson J.C., Gibson R.L., and Burns J.L. Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection. J Antimicrob Chemother 56 (2005) 879-886
66. Murphy K.D., Lee J.O., and Herndon D.N. Current pharmacotherapy for the treatment of severe burns. Expert Opin Pharmacother 4 (2003) 369-384
67. Ko W.C., and Chuang Y.C. Aeromonas bacteremia: review of 59 episodes. Clin Infect Dis 20 (1995) 1298-1304